诺和诺德Novo Nordisk (NVO) 2004年年度报告「NYSE」.pdf

1、ANNUAL REPORT 2004FINANCIAL,SOCIAL AND ENVIRONMENTAL PERFORMANCEREPORTIncluding financial and non-financialperformance data pages 41105Getting on with my lifeAdvances in insulin therapy make the differenceTime to actDiabetes is a time bomb in the developing worldthe developMovers and shakersEmbracin

2、g the globeDriving forceInnovation and balance drive business success28203802REPORTANNUAL REPORT 2004Defeating diabetes02CAN DIABETES REALLY BE DEFEATED?Defeating diabetes demands social leadership and scientificbreakthroughs.It all comes down to prevention.12GETTING ON WITH MY LIFEDiabetes is as co

3、mplex and variable as peoples individualpersonalities and lifestyles,which is why there is no one-size-fits-all insulin therapy.Innovation20WHEN TIME IS RUNNING OUTNovoSevenmay save lives and prevent severe disabil-ities in many life-threatening situations.26RESEARCH AND DEVELOPMENT PIPELINECompetit

4、ive business results10DRIVING FORCENovo Nordisk answers questions on its short-and long-termbusiness strategy.38PERFORMANCE HIGHLIGHTS41FINANCIAL&NON-FINANCIAL PERFORMANCE DATAThe management report,Triple Bottom Line performance in-dicators,financial,environmental and social highlights,reviewof corp

5、orate governance and risk management,financial ac-counts and notes,and non-financial accounting policies.108SHAREHOLDER INFORMATIONChallenging workplace32GLOBAL EXPANSIONWith a worldwide sales organisation and customers in everycorner of the globe,Novo Nordisk is working towards be-coming more inter

6、national.34LEADING WITH PASSIONA strategy for developing talent and diversity is key for NovoNordisks future growth.Values in action18AN INDUSTRY UNDER FIREThe pharmaceutical industry is being challenged on every-thing from access to medicine,drug pricing and marketingto the conduct of clinical tria